about
The genome sequence of the colonial chordate, Botryllus schlosseriHuman-induced pluripotent stem cell models of inherited cardiomyopathiesSuccesses and challenges of using whole exome sequencing to identify novel genes underlying an inherited predisposition for thoracic aortic aneurysms and acute aortic dissectionsTargeting the ubiquitin-proteasome system in heart disease: the basis for new therapeutic strategiesMutation-Specific Phenotypes in hiPSC-Derived Cardiomyocytes Carrying Either Myosin-Binding Protein C Or α-Tropomyosin Mutation for Hypertrophic Cardiomyopathy.Recent Advances in the Molecular Genetics of Familial Hypertrophic Cardiomyopathy in South Asian DescendantsNon-proliferative and Proliferative Lesions of the Cardiovascular System of the Rat and MouseMutations in filamin C cause a new form of familial hypertrophic cardiomyopathyLong term ablation of protein kinase A (PKA)-mediated cardiac troponin I phosphorylation leads to excitation-contraction uncoupling and diastolic dysfunction in a knock-in mouse model of hypertrophic cardiomyopathyStudy familial hypertrophic cardiomyopathy using patient-specific induced pluripotent stem cellsMybpc3 gene therapy for neonatal cardiomyopathy enables long-term disease prevention in miceMYBPC3 in hypertrophic cardiomyopathy: from mutation identification to RNA-based correctionA novel and practical cardiovascular magnetic resonance method to quantify mitral annular excursion and recoil applied to hypertrophic cardiomyopathy.Desensitization of myofilaments to Ca2+ as a therapeutic target for hypertrophic cardiomyopathy with mutations in thin filament proteins.Next-generation sequencing identifies pathogenic and modifier mutations in a consanguineous Chinese family with hypertrophic cardiomyopathy.Gene expression analyses of mouse aortic endothelium in response to atherogenic stimuliHypertrophic cardiomyopathy associated Lys104Glu mutation in the myosin regulatory light chain causes diastolic disturbance in miceMolecular genetics made simple.Molecular modeling of disease causing mutations in domain C1 of cMyBP-CElevated Ca2+ transients and increased myofibrillar power generation cause cardiac hypercontractility in a model of Noonan syndrome with multiple lentigines.Energy Deregulation Precedes Alteration in Heart Energy Balance in Young Spontaneously Hypertensive Rats: A Non Invasive In Vivo31P-MR Spectroscopy Follow-Up Study.Investigation of Pathogenic Genes in Chinese sporadic Hypertrophic Cardiomyopathy Patients by Whole Exome SequencingNano-Biomechanical Study of Spatio-Temporal Cytoskeleton Rearrangements that Determine Subcellular Mechanical Properties and Endothelial PermeabilityA new titinopathy: Childhood-juvenile onset Emery-Dreifuss-like phenotype without cardiomyopathyMimics of Hypertrophic Cardiomyopathy - Diagnostic Clues to Aid Early Identification of Phenocopies.Myosin regulatory light chain phosphorylation enhances cardiac β-myosin in vitro motility under load.Molecular consequences of the R453C hypertrophic cardiomyopathy mutation on human β-cardiac myosin motor function.Echocardiographic Characterization of a Murine Model of Hypertrophic Obstructive Cardiomyopathy Induced by Cardiac-specific Overexpression of Epidermal Growth Factor Receptor 2.Nonlinear cross-bridge elasticity and post-power-stroke events in fast skeletal muscle actomyosin.Delineation of Molecular Pathways Involved in Cardiomyopathies Caused by Troponin T MutationsLoss of the AE3 Cl(-)/HCO(-) 3 exchanger in mice affects rate-dependent inotropy and stress-related AKT signaling in heart.Sex-related differences in the associations between plasma free fatty acid levels and clinical features in patients with hypertrophic cardiomyopathy.Discrete effects of A57G-myosin essential light chain mutation associated with familial hypertrophic cardiomyopathyHypertrophic cardiomyopathy in 2013: Current speculations and future perspectives.Effect of cellular and extracellular pathology assessed by T1 mapping on regional contractile function in hypertrophic cardiomyopathy.Hypertrophic cardiomyopathy: The need for randomized trialsA potential role for integrin signaling in mechanoelectrical feedback.Signalling in sarcomeres in development and disease.Insights into the effects of disease-causing mutations in human actins.A rising titan: TTN review and mutation update.
P2860
Q21128793-8B6CF874-A238-4550-892F-DF6E50DE8DCAQ26852052-0F2C7FDF-496E-4E5B-BEA6-ED596BFFFDE4Q26864938-50632C72-AC02-42BA-BC50-DCED9328D484Q27026951-6FCBDC26-C848-4D0E-AC58-8F9A0C2BA127Q27314792-C9A1F4C7-A290-4F37-B1F4-99EC09A27AE7Q28075331-399C852F-32C2-46C2-943C-941DC74DDEA4Q28079801-D2EB27AB-5F12-4B51-8851-C7EF30FC2F80Q28115580-4FB82EE3-A47B-499B-90B6-CF42C7CFC68BQ28242903-04F468C9-EE83-4724-9848-73DAC225556DQ28247689-AADA32C5-D6B1-4FBB-898C-795E2452E3CEQ28253008-A3DF4DA2-679C-4011-86D5-7A5326EDF257Q28304022-5881B078-C101-4BED-ACDC-A367691FE2ACQ33700642-C21B5126-2C3A-4ABA-A6D2-C1B8E752E8B5Q33771564-B611DA52-352E-44AB-A727-555A9326B042Q33818019-77C81C9A-76C4-4023-81D3-87A984E472ABQ33927042-8DD2525E-5214-42A9-9FC0-E65F1F47EE49Q33969167-3C9E1192-69D7-48E0-B840-553206FD04F1Q34553729-5E032225-1AB2-4383-81F2-6107169A84B9Q34634846-E16189B8-C5F2-4570-9B6F-EA233EFB92E9Q36000046-38D917A2-A5B9-4480-A45F-6DBFDF669C30Q36131208-9151BD2F-DD73-48CC-8B4B-20AAB9E9B9AAQ36287303-8DAC3957-52ED-42C1-A722-026A86E9AB81Q36293495-892FDCC4-F2EB-48A4-9AD1-D5F2F948131DQ36405878-943427AC-1494-4650-832A-95D0352B224CQ36458794-6CC1E523-B98E-4A5E-B688-F8B358026F56Q36683854-90D6F633-9359-416D-ABB4-9E2F84C8E2B3Q37068634-C0BA0284-0E74-4783-B748-3A3E88387893Q37171740-C4FD54E3-4BC2-4145-99FA-5BFB94C5A666Q37232077-A3766D21-85E0-45CB-A90E-947A37E6CBD9Q37372239-5B8D9DD0-53EF-4F16-95F3-05434A5752CEQ37420377-105B5D2C-EBED-4106-8943-5AF8D0A82991Q37440382-92C7EDD1-54C7-4075-B2D6-68FCC41E2C11Q37476496-C73AF0DE-8591-4736-A727-50D48EFD4209Q37603719-88DC9AD4-99E4-4EAE-9BDA-E0512705E15BQ37652430-E61D99E4-5408-4D89-9512-68115969EC34Q37659240-81454801-C9ED-482B-AB88-20BB9D964353Q38028220-9B995A87-D353-4349-BB3D-7F356522AB6EQ38122346-5741EE5A-3B6D-43F9-874A-882B9453ED6FQ38191504-A6E0D8C5-3C48-4756-91F3-D069CA0069BBQ38224878-2B0227A8-BF5F-4A24-982D-ED856E8FFEAA
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Mechanisms of disease: hypertrophic cardiomyopathy.
@en
Mechanisms of disease: hypertrophic cardiomyopathy.
@nl
type
label
Mechanisms of disease: hypertrophic cardiomyopathy.
@en
Mechanisms of disease: hypertrophic cardiomyopathy.
@nl
prefLabel
Mechanisms of disease: hypertrophic cardiomyopathy.
@en
Mechanisms of disease: hypertrophic cardiomyopathy.
@nl
P2093
P2860
P1476
Mechanisms of disease: hypertrophic cardiomyopathy.
@en
P2093
Hugo A Katus
Mark Luedde
Norbert Frey
P2860
P2888
P304
P356
10.1038/NRCARDIO.2011.159
P407
P577
2011-10-25T00:00:00Z
P5875
P6179
1006385240